Q3 2023 Holdings
Filed 2023-11-14 | 52 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $204.5M | 6,470,392 | 13.6% |
| Hillevax Inc | COM | 43157M102 | $131.6M | 9,781,472 | 8.7% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $114.7M | 988,460 | 7.6% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $112.2M | 12,131,705 | 7.5% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $104.8M | 10,109,279 | 7.0% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $71.9M | 2,725,949 | 4.8% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $59.4M | 1,164,405 | 3.9% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $54.4M | 2,371,304 | 3.6% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $49.1M | 3,014,349 | 3.3% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $47.3M | 1,589,931 | 3.1% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $46.1M | 8,684,232 | 3.1% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $34.2M | 2,985,757 | 2.3% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $31.8M | 1,787,527 | 2.1% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $31.2M | 3,238,859 | 2.1% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $30.8M | 655,000 | 2.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $28.7M | 1,403,013 | 1.9% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $27.6M | 997,455 | 1.8% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $23.4M | 614,043 | 1.6% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $22.3M | 1,388,889 | 1.5% |
| Merus N V | COM | N5749R100 | $17.6M | 746,479 | 1.2% |
| Aerovate Therapeutics Inc | COM | 008064107 | $16.4M | 1,204,867 | 1.1% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $16.2M | 899,700 | 1.1% |
| Savara Inc(SVRA) | COM | 805111101 | $15.1M | 4,000,000 | 1.0% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $15.0M | 6,881,090 | 1.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $14.6M | 1,501,383 | 1.0% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $14.3M | 1,050,483 | 1.0% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $14.2M | 1,028,013 | 0.9% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $13.7M | 464,937 | 0.9% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $13.1M | 630,897 | 0.9% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $13.0M | 2,142,855 | 0.9% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $8.7M | 3,746,857 | 0.6% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $8.7M | 600,000 | 0.6% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $8.7M | 881,173 | 0.6% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $8.6M | 393,000 | 0.6% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $8.5M | 400,000 | 0.6% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $8.4M | 1,803,204 | 0.6% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $7.2M | 292,002 | 0.5% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $6.6M | 386,762 | 0.4% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $6.4M | 203,684 | 0.4% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $6.2M | 127,900 | 0.4% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $6.0M | 2,248,194 | 0.4% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $5.6M | 285,331 | 0.4% |
| Bluebird BIO Inc | COM | 09609G100 | $5.2M | 1,709,907 | 0.3% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $4.9M | 849,022 | 0.3% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $4.7M | 370,000 | 0.3% |
| Sutro Biopharma Inc | COM | 869367102 | $2.7M | 780,000 | 0.2% |
| Gritstone BIO Inc(2JQ) | COM | 39868T105 | $2.5M | 1,430,878 | 0.2% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $1.8M | 264,377 | 0.1% |
| Syndax Pharmaceuticals Inc(SNDX)Put | COM | 87164F105 | $1.6M | 600,000 | 0.1% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $1.5M | 1,647,030 | 0.1% |